Changes in plasma brain natriuretic peptide and norepinephrine over time and subsequent mortality and morbidity in heart failure: Results from Val-HeFT

Inder S. Anand; Lloyd D. Fisher; Yann-Tom Chiang; Roberto Latini; Serge Masson; Aldo Maggioni; Robert Glazer; Gianni Tognoni; Jay N. Cohn

doi:10.1016/s0735-1097(03)81615-7

Back

Changes in plasma brain natriuretic peptide and norepinephrine over time and subsequent mortality and morbidity in heart failure: Results from Val-HeFT

Article 2003 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand, Lloyd D. Fisher, YannTong Chiang, Roberto Latini, Serge Masson, Aldo Maggioni, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2002

The predictive value of combinations of different levels of brain natriuretic peptide and norepinephrine in the Val-HeFT trial

Inderiit S. Anand, Roberto Latini, Serge Masson, Dianne Judd, Aldo Maggioni, Robert Glazer, Tom Chiang, Philippe Lechat, Gianni Tognoni, Jay N. Cohn

Article2003

Prognostic Value of Aldosterone in Heart Failure – Results from Val-HeFT

Inder S. Anand, Roberto Latini, Robert Glazer, Allen Hester, Serge Masson, Aldo Maggioni, Nora Aknay, Jay N. Cohn

Article2004

1163-114 Prognostic role of plasma C-reactive protein in heart failure: Results from Val-HeFT

Inder S. Anand, Roberto Latini, Serge Masson, Dianne Judd, YannTong Chiang, Robert Glazer, E. W. T. Morris, Aldo Maggioni, Gianni Tognoni, Stefano Signorini, Jay N. Cohn

Article2003

The relationship between B-type natriuretic peptide, heart structure, and function in 4,300 patients with heart failure enrolled to Val-HeFT

Roberto Latini, Serge Masson, Lidia Staszewsky, Aldo Maggioni, Alberto Volpi, Simona Barlera, Inder S. Anand, Allen Hester, Maylene Wong, Jay N. Cohn